Related Experiment Video
Updated: Aug 13, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Comparative efficacy of eight therapeutic methods in the treatment of left main coronary artery disease: a Bayesian
Biao Hou1, Manlin Chen2, Qin Li1
1Inner Mongolia Medical University, Hohhot, China.
Insights
This network meta-analysis compares surgical treatments for left main coronary artery (LMCA) disease. It aims to rank the long-term efficacy and safety of various surgical methods for LMCA lesions.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Evidence-Based Medicine
Background:
- Direct comparative studies on minimally invasive versus traditional thoracotomy for coronary artery bypass grafting are numerous.
- However, a comprehensive ranking and summary of all surgical methods for left main coronary artery (LMCA) lesions are lacking.
- Existing views on LMCA disease treatment remain controversial.
Purpose of the Study:
- To conduct a planned network meta-analysis (NMA) comparing the long-term efficacy and safety of multiple therapeutic methods for LMCA disease.
- To provide a reference for selecting optimal clinical strategies for LMCA lesions.
- To address the current lack of ranked evidence for surgical interventions in LMCA disease.
Main Methods:
- A systematic literature search of PubMed, Embase, Web of Science, and The Cochrane Library from inception to June 2022.
- Inclusion of randomized controlled trials (RCTs) evaluating different surgical methods for LMCA disease.
- Bayesian network meta-analysis using STATA V.16.0, assessing methodological quality via the Cochrane risk of bias tool.
Main Results:
- Primary outcomes include major adverse cardiovascular events (mortality, myocardial infarction, stroke, revascularization).
- Secondary outcomes encompass operation-related time, blood transfusion, complications (e.g., atrial fibrillation, wound infection), functional scores, return to work, and costs.
- The NMA will provide a ranked comparison of surgical interventions for LMCA disease.
Conclusions:
- This study will synthesize evidence to rank surgical interventions for LMCA disease.
- The findings will inform clinical decision-making for treating LMCA lesions.
- A comprehensive comparison of efficacy and safety will be presented.
Introduction:
As for coronary artery bypass grafting, although there are many direct comparative studies on different minimally invasive methods and traditional thoracotomy (off-pump/on-pump), there is still a lack of further ranking and summary of the efficacy of all surgical methods for left main coronary artery (LMCA) lesions. Combined with the current controversial views, this study aims to introduce a planned network meta-analysis (NMA) in detail, with a view to comparing the long-term efficacy and safety of multiple therapeutic methods in the treatment of patients with LMCA disease, and finally providing some reference bases for the best selection of clinical schemes.
Method And Analysis:
PubMed, Embase, Web of Science and The Cochrane Library databases will be collected from inception to June 2022 to compare the efficacy of different surgical methods in randomised controlled trials (RCTs) for LMCA disease. Main outcome endpoints: major adverse cardiovascular events, including mortality, myocardial infarction, stroke and revascularisation. Secondary outcome endpoints: (1) operation-related time, (2) the amount of blood transfusion, (3) complications including secondary thoracotomy, postoperative new atrial fibrillation, wound infection, (4) physiological score and psychological score, (5) time return to work and (6) total hospitalisation costs. The methodological quality of included RCTs will be assessed according to the Cochrane bias risk table. The Bayesian NMA will be conducted by STATA V.16.0.
Ethics And Dissemination:
The essence of this study is to summarise and analyse the original data without the approval of the ethics committee. Our research does not involve ethical issues, and the results will be published in peer-review journals.
Prospero Registration Number:
CRD42021274712.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology